Résultats de "Fortrea" dans Toutes les catégories

We take you inside Fortrea’s EPON model, where early phase innovation meets operational excellence. Through conversations with medical leaders, investigators, and site engagement experts, we unpack how specialized site models, strategic geography, and deep scientific collaboration accelerate first in human and early phase oncology studies.

Welcome to Hope in a Dose—the podcast where we explore the science, strategy, and stories behind the therapies redefining what’s possible. Designed for CGT innovators, this series helps you move smarter, faster, and with greater operational confidence. Across each episode, we unpack the real-world challenges sponsors face today: selecting truly CGT-capable sites, navigating early-phase risk, activating global trials in rare populations, and demonstrating meaningful clinical impact. Hosted by Lousie Kearney Head of Cell and Gene Therapy, Strategy and Delivery at Fortrea, a seasoned leader ...

Here we explore the evolving landscape of ophthalmology clinical trials and look ahead to the most promising trends shaping the future of ophthalmology trials.

Cybersecurity isn't an exact science. It's where art and science meet, informed by experience, tested in battle and reimagined to tackle evolving adversaries. In The Art of Security, Josh Davies and Tyler Reguly break down how security actually works in practice. From zero-day exploits and emerging threats to rethinking long-standing best practices, they explore what holds up — and what doesn't — in today's rapidly changing landscape. While the science of cybersecurity focuses on what's repeatable, the art of security is about making the right decisions in the moment. Each episode delivers...

Exploring the evolving role clinical trials in rare disease treatment and imaging in precision oncology. We discuss the latest advancements in imaging and the design of clinical studies.

This podcast series spotlights innovations in cardiovascular medicine and clinical research. We explore coronary inflammation as a new frontier in risk management, featuring insights on residual risk, landmark trials, and Abcentra’s monoclonal antibody approach. Then we delve into advanced imaging and trial design strategies for targeted therapies, emphasizing precision medicine and the role of novel endpoints in accelerating development. Together, these conversations highlight emerging science, collaborative solutions, and the shift toward personalized cardiovascular care.

Diabetes Dialogues is a thought-provoking podcast series that dives deep into the science, challenges, and human stories shaping Type 1 diabetes research and care. Each episode brings together leading experts and advocates to explore breakthroughs in cell and gene therapies, the realities of clinical trial access, and the unique needs of both adult and pediatric populations. Through candid conversations, the series highlights how innovation and inclusion must go hand in hand to create a future without T1D, offering practical insights, emerging tools, and a shared vision for transforming ...

This podcast series from Fortrea dives into the cutting edge of neuroscience research and clinical innovation. Hosted by Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology, each episode brings together industry leaders and Fortrea experts to explore how technology, data, and strategy are reshaping trials for neurological disorders.

In this series, we discuss the evolving landscape of obesity drug development, exploring the science, patient experiences, and clinical trial innovations that are shaping a new era in care. Through candid conversations with advocates like Sarah Le Brocq and expert insights from host Claudia Filozof, the podcast examines obesity as a complex, chronic disease—challenging stigma, highlighting the importance of empathy in healthcare, and advocating for patient-centric approaches in clinical research.

This podcast provides deep insights into the evolving landscape of clinical trials, with a strong emphasis on sustainability and innovation. We explore innovative strategies to drive sustainability and discuss the current state of sustainability in clinical trials, industry focus areas, and the impact on patients.

In this series, we discuss how to drive productivity in biotech clinical trials and how to maximize valuation for minimal investment. Historically, R&D productivity has always been an area of focus and priority for the industry, but recent trends are particularly challenging. How do you realize this ultimate goal as protocols are becoming increasingly complex?

Cybersecurity Ally is Fortra's cybersecurity podcast covering security, today's cyber threats, and everything you need for cyber news today. Listen now!